You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Follicular lymphoma (FL)

Showing 26 - 50 of 6,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Lymphoma Trial in Worldwide (Nivolumab)

Completed
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +44 more
Dec 13, 2021

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • voruciclib monotherapy
  • voruciclib and venetoclax
  • Duarte, California
  • +10 more
Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022

Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Idasanutlin, Obinutuzumab, Venetoclax)

Terminated
Has Results
  • Follicular Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Aurora, Colorado
  • +20 more
Dec 5, 2021

Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

Completed
Has Results
  • Marginal Zone Lymphoma
  • +2 more
  • Harbin, Heilongjiang, China
  • +3 more
Oct 26, 2021

Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62 Injection,

Recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62 Injection
  • Lenalidomide
  • Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
Jun 15, 2021

Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory DLBCL Trial in Spain, United Kingdom, United States

Completed
  • Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Marietta, Georgia
  • +27 more
Feb 4, 2022

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

Completed
Has Results
  • Follicular Lymphoma (FL/Indolent NHL)
  • +4 more
  • Huntsville, Alabama
  • +22 more
Apr 1, 2022

Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

Not yet recruiting
  • Follicular Lymphoma
  • Low Grade Non-Hodgkin's Lymphoma, Adult
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)

Recruiting
  • Lymphoma
  • +2 more
  • Bruxelles, Belgium
  • +30 more
Jul 23, 2021

Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

Not yet recruiting
  • Follicular Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Fort Myers, Saint Petersburg, Nashville (Ublituximab, Umbralisib)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
Jul 20, 2022

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma (MZL)
  • Chiang Mai, Thailand
    Chiang Mai University
Nov 20, 2023

Lymphoma, Follicular Trial (Mosunetuzumab)

Not yet recruiting
  • Lymphoma, Follicular
  • (no location specified)
May 8, 2023

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Fresno, California
  • +2 more
Jan 24, 2023

Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)

Active, not recruiting
  • Indolent Non-hodgkin Lymphoma
  • Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
Oct 3, 2022

DLBCL, Lymphoma Follicular Trial in Australia, Italy, United States (Atezolizumab, Bendamustine, Cyclophosphamide)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
  • Aurora, Colorado
  • +20 more
Apr 26, 2021

Advanced Follicular Lymphoma:Translational Study From FIL_FOLL12

Not yet recruiting
  • Follicular Lymphoma
  • EZH2 mutations/CNAs by droplet digital PCR (ddPCR)
  • EZH2-derived gene expression signature by RNA-Seq
  • Alessandria, Italy
  • +25 more
Apr 4, 2023

CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) Trial

Not yet recruiting
  • CD5+ Relapsed/Refractory Hematopoietic Malignancies
  • +5 more
  • CT125A cells
  • Cyclophosphamide, fludarabine
  • (no location specified)
Feb 19, 2021